Accelerated Technologies Partners logo

Accelerated Technologies Partners

North America, New York, United States, New York

Description

Accelerated Technologies Partners (ATP) is an investment partnership that focuses on medical devices.

Investor Profile

Accelerated Technologies Partners has made 6 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (33%)
  • Series B (33%)
  • Series Unknown (33%)

Country Focus

  • United States (83%)
  • Germany (17%)

Industry Focus

  • Health Care
  • Medical
  • Medical Device
  • Genetics
  • Health Diagnostics
  • Biotechnology
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Accelerated Technologies Partners frequently co-invest with?

ABN AMRO Fund
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Medica Venture Partners
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 1
Triathlon Medical Venture Partners
North America, Ohio, United States, Cincinnati
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
Bioventures Investors
North America, Massachusetts, United States, Wellesley
Co-Investments: 2
Commons Capital
North America, Massachusetts, United States, Brookline
Co-Investments: 2
AAC Capital Partners
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 6
Giza Venture Capital
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 4

What are some of recent deals done by Accelerated Technologies Partners?

Claros Diagnostics

Miami, Florida, United States

Claros Diagnostics develop blood testing devices for use in homes and doctors offices for tests typically performed in a laboratory.

GeneticsHealth CareHealth Diagnostics
Series BMar 23, 2009
Amount Raised: $4,000,000
Claros Diagnostics

Miami, Florida, United States

Claros Diagnostics develop blood testing devices for use in homes and doctors offices for tests typically performed in a laboratory.

GeneticsHealth CareHealth Diagnostics
Series AJan 19, 2007
Amount Raised: $7,800,000
Mitralign

Tewksbury, Massachusetts, United States

Mitralign is focused on developing a catheter-based technology for the percutaneous treatments of functional mitral regurgitation.

Health CareMedicalMedical Device
Series BJun 30, 2006
Amount Raised: $13,000,000
Mitralign

Tewksbury, Massachusetts, United States

Mitralign is focused on developing a catheter-based technology for the percutaneous treatments of functional mitral regurgitation.

Health CareMedicalMedical Device
Series UnknownJun 8, 2005
Amount Raised: $6,700,000
Mitralign

Tewksbury, Massachusetts, United States

Mitralign is focused on developing a catheter-based technology for the percutaneous treatments of functional mitral regurgitation.

Health CareMedicalMedical Device
Series AMay 10, 2004
Amount Raised: $3,500,000
Impella Cardiosystems

Aachen, Nordrhein-Westfalen, Germany

Impella CardioSystems AG, based in Aachen, Germany, develops, manufactures and markets minimally invasive cardiovascular support systems

BiotechnologyHealth CareManufacturing
Series UnknownJan 1, 2003
Amount Raised: $40,000,000